Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1465-542X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade ; volume:19 ; number:1 ; day:4 ; month:8 ; year:2017 ; pages:1-14 ; date:12.2017
Breast cancer research ; 19, Heft 1 (4.8.2017), 1-14, 12.2017

Keyword: Krebs
Onkologie

Creator: Martin, Janet L.

Contributor: Julovi, Sohel M.
Lin, Mike Z.
de Silva, Hasanthi C.
Boyle, Frances M.
Baxter, Robert C.
SpringerLink (Online service)

DOI: 10.1186/s13058-017-0882-x

URN: urn:nbn:de:1111-201710209915

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:27 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Martin, Janet L.
Julovi, Sohel M.
Lin, Mike Z.
de Silva, Hasanthi C.
Boyle, Frances M.
Baxter, Robert C.
SpringerLink (Online service)

Other Objects (12)

Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

Profiling and metaanalysis of epidermal keratinocytes responses to epidermal growth factor

Growth and biomechanics of plant epidermal cells

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Correction to: FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors

Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

Profiling and metaanalysis of epidermal keratinocytes responses to epidermal growth factor

Growth and biomechanics of plant epidermal cells

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Correction to: FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors

Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

Profiling and metaanalysis of epidermal keratinocytes responses to epidermal growth factor

Growth and biomechanics of plant epidermal cells

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Correction to: FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read and agree to the privacy policy for the collection of personal data.*

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade

Show object

References and Relationships

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

Profiling and metaanalysis of epidermal keratinocytes responses to epidermal growth factor

Growth and biomechanics of plant epidermal cells

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Correction to: FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors

Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

Profiling and metaanalysis of epidermal keratinocytes responses to epidermal growth factor

Growth and biomechanics of plant epidermal cells

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Correction to: FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors

Targeting the Transforming Growth Factor-β pathway inhibits human basal-like breast cancer metastasis

Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype

1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice

FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors

Inactivation of LATS1/2 drives luminal-basal plasticity to initiate basal-like mammary carcinomas

Weight loss reduces basal-like breast cancer through kinome reprogramming

Profiling and metaanalysis of epidermal keratinocytes responses to epidermal growth factor

Growth and biomechanics of plant epidermal cells

Basal-like breast cancer: molecular profiles, clinical features and survival outcomes

Targeting BCL-2–expressing basal-like breast cancer with BH3-mimetics

The CD44+/CD24-phenotype is enriched in basal-like breast tumors

Correction to: FAK activates AKT-mTOR signaling to promote the growth and progression of MMTV-Wnt1-driven basal-like mammary tumors

Related objects

Reset password